Elanco: restructuring measures

(CercleFinance.com) - Veterinary medicines group Elanco Animal Health has announced measures to simplify the organisational structure, drive profitable growth and focus investment on growth and innovation opportunities.


The measures include approximately 380 redundancies, resulting in a charge to net income of 65 to 71 million dollars in Q4 2021, although generating savings of approximately 70 million dollars when fully implemented.

The savings of approximately 60 million dollars in 2022 will help to offset additional inflationary costs, generate further productivity savings and enable focused investment to drive growth and innovation.

The share is pretty flat this lunchtime, having fluctuated around the 30-dollar mark over most of this year.


Copyright (c) 2021 CercleFinance.com. All rights reserved.